Cutaneous Hydration Assessment in SCD

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
Enrico Novelli
Study ID
NCT05210114
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Skin Hydration Sensor — DEVICE
    The device is a skin hydration sensor. The sensor is placed on the skin at the inner arm. It is non-invasive and measures in seconds the percent water content of the dermis by quantifying its dielectric constant.

Study Details

This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).

Key Dates

Start date
Jan 21, 2022
Status verified
Nov 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Skin Hydration Sensor

Primary Outcome Measure

Dermal water content measurements in SCD participants at baseline state of health [ Time Frame: During a regularly scheduled clinic appointment, approximately 2 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UPMC Sickle Cell ClinicPittsburghPennsylvania15213
Enrico Novelli, MD
[email protected]
412-916-3416
Manzoor Mohideen, PhD
[email protected]
412-802-8498
Enrico Novelli, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Pittsburgh, PA

By condition
Sickle cell disease
By research site
UPMC Sickle Cell Clinic· Pittsburgh, PA

Related Studies